Pumping the brakes on autoimmune disease

A new study from researchers at Sanford Burnham Prebys and Eli Lilly and Company describes the science behind an autoimmune disease treatment in a Phase 2 clinical trial.

Is San Diego’s rooftop solar boom over? Not at Sanford Burnham Prebys

Many in the county are facing barriers to adopting solar energy, but Sanford Burnham Prebys is leading the charge with a $2.5 million investment in solar power.

Back by popular demand: The Rising Stars Symposium at Sanford Burnham Prebys

The annual event aims to foster greater diversity in biomedical research and shine a spotlight on the next generation of scientific leaders.

Presenting The Conrad Prebys Foundation fellows

A new educational program at Sanford Burnham Prebys has welcomed a diverse group of early-career scientists to learn how to transform research discoveries into treatments for human diseases.